Acute Rheumatic Fever without Mention of Cardiac Involvement (ICD-11: 1B40)

1. Introduction

Acute rheumatic fever without mention of cardiac involvement represents a specific form of systemic inflammatory response that occurs as a late complication of oropharyngeal infections caused by beta-hemolytic streptococci of group A. This condition is characterized by the presence of articular, neurological, or cutaneous manifestations of rheumatic fever, but without documented evidence of cardiac structure involvement at the time of diagnosis.

The clinical importance of this condition lies in the fact that, although it does not present documented cardiac involvement in the acute phase, patients still require careful surveillance and appropriate treatment to prevent recurrences and possible future complications. Rheumatic fever remains a significant cause of morbidity in populations with limited access to adequate health care, particularly in regions with high prevalence of untreated streptococcal infections.

From an epidemiological perspective, acute rheumatic fever represents a considerable public health problem in various parts of the world, especially in communities with unfavorable socioeconomic conditions, overcrowding, and restricted access to appropriate antibiotic therapy. The disease predominantly affects children and adolescents between 5 and 15 years of age, although it can occur in other age groups.

Correct coding of this condition is critical for multiple reasons. First, it enables appropriate epidemiological monitoring and identification of areas with higher prevalence, facilitating the implementation of primary and secondary prevention programs. Second, the clear distinction between forms with and without cardiac involvement is essential for determining follow-up protocols, prognosis, and specific therapeutic strategies. Third, accurate documentation contributes to research on the natural history of the disease and efficacy of preventive interventions. Finally, appropriate coding ensures adequate reimbursement by health systems and allows correct allocation of resources for the management of this potentially serious condition.

2. Correct ICD-11 Code

Code: 1B40

Description: Acute rheumatic fever without mention of cardiac involvement

Parent category: Acute rheumatic fever

This specific ICD-11 code was developed to classify cases of acute rheumatic fever in which the documented clinical manifestations do not include signs or symptoms of cardiac compromise. The absence of "mention" of cardiac involvement means that, based on the available clinical evaluation, complementary examinations performed, and existing medical documentation, there is no evidence of rheumatic carditis at the time of diagnosis.

It is fundamental to understand that this code does not necessarily imply that the heart is completely spared at the microscopic or subclinical level, but rather that there are no detectable clinical or paraclinical manifestations of cardiac involvement during acute presentation. The classification reflects the documented clinical reality and serves as a basis for therapeutic and prognostic decisions.

The hierarchical structure of ICD-11 positions this code within the broader spectrum of acute rheumatic diseases, allowing both specific and aggregate epidemiological analyses. This organization facilitates understanding of the relationships between different presentations of rheumatic fever and assists healthcare professionals in navigating the classification system.

The use of this code requires clear documentation that a cardiovascular evaluation was performed or considered, and that the findings did not demonstrate cardiac involvement. This distinction is crucial to differentiate cases truly without cardiac compromise from those in which adequate cardiovascular evaluation was simply not performed.

3. When to Use This Code

Code 1B40 should be applied in specific clinical situations where diagnostic criteria for acute rheumatic fever are satisfied, but without evidence of cardiac involvement. Below, we present detailed practical scenarios:

Scenario 1: Post-Streptococcal Migratory Polyarthritis A 12-year-old adolescent presents with a history of pharyngitis three weeks prior, followed by the development of migratory arthritis affecting knees, ankles, and wrists. The patient presents with fever, intense joint pain with inflammatory signs, and functional limitation. Laboratory tests demonstrate elevation of inflammatory markers (ESR and C-reactive protein), serological evidence of recent streptococcal infection (elevated ASLO), and complete cardiovascular evaluation, including physical examination, electrocardiogram, and echocardiogram, reveals no abnormalities. In this case, code 1B40 is appropriate, as there is a major manifestation (arthritis) without documented cardiac involvement.

Scenario 2: Erythema Marginatum with Minor Articular Manifestations An 8-year-old child develops characteristic skin lesions of erythema marginatum, accompanied by arthralgias (without frank arthritis) and low-grade fever. History reveals inadequately treated throat infection one month prior. Markers of streptococcal infection are positive, and clinical and echocardiographic cardiac evaluation demonstrates no changes. The presence of a major manifestation (erythema marginatum) combined with minor manifestations, without cardiac involvement, justifies the use of code 1B40.

Scenario 3: Subcutaneous Nodules in Rheumatic Context A 10-year-old patient presents with painless subcutaneous nodules over bony prominences, particularly on elbows and knees, associated with fever and history of confirmed recent streptococcal pharyngitis. Laboratory tests are compatible with acute inflammatory process, and complete cardiovascular investigation identifies no signs of carditis. This clinical presentation, with a major cutaneous manifestation without cardiac compromise, is appropriately coded as 1B40.

Scenario 4: Recurrent Rheumatic Arthritis without Carditis An adolescent with previous history of acute rheumatic fever, appropriately treated and on secondary prophylaxis, presents with a new episode of migratory arthritis following temporary interruption of antibiotic prophylaxis and exposure to streptococcal infection. Current evaluation demonstrates typical arthritis, elevated inflammatory markers, but echocardiogram remains normal without evidence of new carditis or worsening of previous lesions (if present). Code 1B40 is applicable for this recurrence without acute cardiac involvement.

Scenario 5: Prolonged Post-Streptococcal Articular Manifestations A 7-year-old child develops symmetric polyarthritis involving large joints, lasting more than two weeks, following a documented episode of streptococcal pharyngitis. Modified Jones criteria are satisfied with major and minor manifestations, but all cardiovascular evaluations (careful auscultation, ECG, and echocardiogram) remain normal. Clear documentation of the absence of cardiac involvement makes code 1B40 appropriate.

Scenario 6: Rheumatic Fever with Complete Therapeutic Response A 14-year-old patient diagnosed with acute rheumatic fever based on clinical and laboratory criteria, presenting with arthritis and fever as main manifestations. Following initial normal cardiovascular evaluation and institution of appropriate anti-inflammatory treatment, there is complete resolution of articular symptoms. Follow-up echocardiogram confirms absence of cardiac involvement. Code 1B40 appropriately documents this case of rheumatic fever without carditis.

4. When NOT to Use This Code

Inappropriate application of code 1B40 can result in inaccurate documentation and suboptimal clinical management. It is essential to recognize situations where this code is not appropriate:

Presence of Any Cardiac Involvement Code 1B40 should not be used when there is any evidence of acute rheumatic carditis, even if subtle. This includes new or altered cardiac murmurs, signs of pericarditis (pericardial friction rub, electrocardiographic changes), echocardiographic evidence of valvulitis (new mitral or aortic regurgitation), radiological cardiomegaly, or signs of heart failure. Even subtle echocardiographic findings of valvular involvement require coding as 1B41 (with cardiac involvement).

Isolated Sydenham Chorea When the predominant or isolated manifestation is rheumatic chorea (involuntary movements, motor incoordination, emotional lability), the appropriate code is 1B42, even in the absence of cardiac involvement. Chorea represents a distinct clinical entity within the spectrum of acute rheumatic fever and has a specific code.

Inadequate or Absent Cardiovascular Evaluation If a patient presents with manifestations compatible with acute rheumatic fever but has not undergone appropriate cardiovascular evaluation (including careful physical examination and, ideally, echocardiogram), code 1B40 should not be applied prematurely. The "absence of mention" of cardiac involvement presupposes that an evaluation was performed and did not identify abnormalities, not that it simply was not investigated.

Chronic Rheumatic Heart Disease Patients with chronic sequelae of previous rheumatic fever, such as established valvular disease, should be coded with appropriate codes for chronic rheumatic heart disease, not with 1B40, which refers specifically to the acute episode.

Arthritis of Other Etiologies Conditions that may mimic acute rheumatic fever, such as post-infectious reactive arthritis from other agents, septic arthritis, juvenile idiopathic arthritis, or articular manifestations of other connective tissue diseases (such as systemic lupus erythematosus), require specific diagnostic codes. Confirmation of recent streptococcal infection and fulfillment of established diagnostic criteria are essential before applying code 1B40.

Streptococcal Pharyngitis without Rheumatic Fever The mere presence of streptococcal oropharyngeal infection, even with transient nonspecific articular manifestations, does not justify the diagnosis of acute rheumatic fever or the use of code 1B40, unless formal diagnostic criteria are satisfied.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The first fundamental step is to confirm that the patient meets the established diagnostic criteria for acute rheumatic fever. The modified Jones criteria constitute the standard diagnostic tool and require evidence of recent streptococcal infection associated with specific major and/or minor manifestations.

Evidence of Recent Streptococcal Infection:

Positive oropharyngeal culture for Streptococcus pyogenes
Positive rapid streptococcal antigen test
Elevated or rising titers of antistreptolysin antibodies (ASLO, anti-DNase B)

Major Manifestations:

Carditis (which, if present, would exclude the use of 1B40)
Polyarthritis or migratory arthritis
Sydenham chorea (specific code 1B42)
Erythema marginatum
Subcutaneous nodules

Minor Manifestations:

Fever
Arthralgias (without frank arthritis)
Elevation of inflammatory markers (ESR, CRP)
Prolongation of PR interval on electrocardiogram

Diagnostic confirmation generally requires two major manifestations or one major manifestation with two minor manifestations, in addition to evidence of recent streptococcal infection.

Step 2: Verify Specifiers

After confirming the diagnosis of acute rheumatic fever, it is essential to adequately characterize the clinical presentation:

Clinical Manifestations Present: Document specifically which major and minor manifestations are present. In the case of code 1B40, manifestations may include arthritis, erythema marginatum, subcutaneous nodules, fever, arthralgias, and elevated inflammatory markers, but not carditis or isolated chorea.

Severity of Manifestations: Assess the intensity of articular symptoms (number of affected joints, degree of functional limitation), the extent of cutaneous manifestations, and the systemic impact of the disease (intensity of fever, patient's general condition).

Duration of Symptoms: Record the time elapsed since symptom onset and the temporal relationship with the preceding streptococcal infection (typically 2-4 weeks after pharyngitis).

Initial Episode versus Recurrence: Identify whether this is the first episode of rheumatic fever or a recurrence in a patient with prior history.

Step 3: Differentiate from Other Codes

1B41: Acute rheumatic fever with cardiac involvement

The key difference between 1B40 and 1B41 lies exclusively in the presence or absence of manifestations of rheumatic carditis. Code 1B41 should be used when there is any evidence of cardiac involvement, including:

New cardiac murmurs (mitral or aortic regurgitation)
Pericarditis (pericardial friction rub, pericardial effusion)
Cardiomegaly
Congestive heart failure
Echocardiographic changes indicative of valvulitis

Careful evaluation with detailed cardiovascular physical examination, electrocardiogram, and echocardiogram is essential for this differentiation. Even subtle echocardiographic findings of valvular regurgitation, if attributable to acute rheumatic carditis, justify the use of 1B41 instead of 1B40.

1B42: Rheumatic chorea

This code is specific for cases where Sydenham chorea (also known as minor chorea or St. Vitus dance) is the predominant or isolated manifestation of rheumatic fever. The key difference is the presence of:

Involuntary, irregular, non-rhythmic movements
Motor incoordination and muscle weakness
Emotional lability
Characteristic neurological manifestations

Chorea may occur in isolation or in association with other manifestations of rheumatic fever. When present as the main manifestation, even in the absence of cardiac involvement, code 1B42 is more specific than 1B40. However, if chorea is a minor manifestation in a clinical picture dominated by arthritis without carditis, there may be debate about which code is most appropriate, with clinical judgment based on the predominant presentation prevailing.

Step 4: Necessary Documentation

Checklist of Mandatory Information:

History of Streptococcal Infection:
- Date and characteristics of preceding pharyngitis
- Treatment performed (if any)
- Interval between infection and onset of rheumatic symptoms
Clinical Manifestations Present:
- Detailed description of arthritis (affected joints, migratory pattern)
- Characteristics of skin lesions (if present)
- Presence and intensity of fever
- Other systemic symptoms
Laboratory Evidence:
- Results of tests for streptococcal infection (ASLO, anti-DNase B, culture)
- Inflammatory markers (ESR, CRP)
- Other relevant complementary tests
Complete Cardiovascular Evaluation:
- Detailed cardiovascular physical examination (cardiac auscultation, screening for signs of heart failure)
- Electrocardiogram results
- Echocardiogram findings (essential to confirm absence of cardiac involvement)
- Chest X-ray (if performed)
Diagnostic Criteria Satisfied:
- Clear specification of which Jones criteria are present
- Justification for the diagnosis of acute rheumatic fever
Exclusion of Cardiac Involvement:
- Explicit statement that there is no evidence of carditis
- Date and method of cardiovascular evaluation

This detailed documentation not only justifies coding as 1B40, but also provides the basis for therapeutic decisions, establishment of prognosis, and planning for long-term follow-up.

6. Complete Practical Example

Clinical Case

Initial Presentation: An 11-year-old female patient, previously healthy, presents to the emergency department with the chief complaint of pain and swelling in multiple joints for five days. The mother reports that the child had "severe sore throat" approximately three weeks ago, which was treated symptomatically at home with analgesics, without seeking medical care at that time.

Joint symptoms began in the right knee, with intense pain, edema, local warmth, and significant limitation of movement. After two days, while the right knee improved partially, the left ankle became painful and swollen. In the last two days, similar symptoms appeared in the wrists. The patient also presents with daily fever, with maximum temperature of 38.5°C, fatigue, and loss of appetite.

Evaluation Performed:

On physical examination, the patient appears in fair general condition, febrile (axillary temperature of 38.2°C), heart rate of 100 bpm, blood pressure of 100/60 mmHg. Joint examination reveals discrete residual edema in the right knee, edema and warmth in the left ankle, and pain on mobilization of both wrists with discrete swelling. There are no joint deformities.

Cardiovascular examination demonstrates rhythmic, normal-sounding heart sounds without audible murmurs. There are no signs of heart failure (absence of jugular venous distension, hepatomegaly, or peripheral edema). Pulmonary examination is normal. No skin lesions or subcutaneous nodules are identified.

Complementary Tests:

Complete blood count: discrete leukocytosis (12,000/mm³) with left shift
ESR: 65 mm in the first hour (reference value: up to 20 mm/h)
C-reactive protein: 45 mg/L (reference value: up to 5 mg/L)
ASLO (antistreptolysin O): 640 IU/mL (reference value: up to 200 IU/mL)
Anti-DNase B: 480 IU/mL (reference value: up to 170 IU/mL)
Electrocardiogram: sinus rhythm, HR 95 bpm, PR interval of 0.16 seconds (normal for age), without repolarization changes
Chest X-ray: normal cardiac area, clear lung fields
Transthoracic echocardiogram: cardiac chambers of normal dimensions, preserved systolic function, mitral and aortic valves with normal morphology and mobility, without significant regurgitation, absence of pericardial effusion

Diagnostic Reasoning:

The patient presents with a clinical picture highly suggestive of acute rheumatic fever. The history of inadequately treated pharyngitis three weeks before symptom onset establishes the appropriate temporal context. The presence of migratory polyarthritis (involving the knee, ankle, and wrists sequentially) constitutes a major manifestation by Jones criteria.

Minor manifestations present include fever and significant elevation of inflammatory markers (ESR and CRP). Laboratory evidence of recent streptococcal infection is robust, with elevation of both ASLO and anti-DNase B.

Applying the modified Jones criteria: one major manifestation (polyarthritis) + two minor manifestations (fever and elevated inflammatory markers) + evidence of recent streptococcal infection = confirmed diagnosis of acute rheumatic fever.

Crucially, the complete cardiovascular evaluation, including detailed physical examination, electrocardiogram, and echocardiogram, demonstrated no evidence of cardiac involvement. There are no murmurs, electrocardiographic changes suggestive of carditis, cardiomegaly, or echocardiographic valvular or pericardial abnormalities.

Coding Justification:

Based on the clinical presentation, laboratory findings, and complete cardiovascular evaluation, the diagnosis of acute rheumatic fever without cardiac involvement is clearly established.

Step-by-Step Coding:

Diagnostic confirmation: Jones criteria satisfied (1 major manifestation + 2 minor + evidence of streptococcal infection)
Identification of present manifestations: Migratory polyarthritis, fever, elevated inflammatory markers
Exclusion of cardiac involvement: Complete cardiovascular evaluation negative for carditis
Exclusion of chorea: No neurological manifestations suggestive of Sydenham's chorea
Code selection: 1B40 - Acute rheumatic fever without mention of cardiac involvement

Code Selected: 1B40

Complete Justification:

Code 1B40 is the most appropriate because:

The diagnosis of acute rheumatic fever is confirmed by established criteria
There is clear documentation of typical manifestations (migratory polyarthritis)
Cardiovascular evaluation was performed adequately and demonstrated no cardiac involvement
There is no isolated chorea that would justify code 1B42
The absence of carditis excludes the use of code 1B41

Applicable Complementary Codes:

Depending on the documentation system and administrative needs, additional codes may be considered for:

Recent streptococcal infection (if documented by culture)
Specific articular manifestations (if system allows additional coding of symptoms)
Fever (if symptom coding is required separately)

Therapeutic Plan and Follow-up:

The patient was started on benzathine penicillin for eradication of remaining streptococci, anti-inflammatory agents for control of joint symptoms, and secondary prophylaxis was established with monthly benzathine penicillin. Outpatient follow-up was scheduled with periodic cardiovascular reevaluation, including echocardiogram in 6 months, given the possibility of late development of subclinical carditis.

7. Related Codes and Differentiation

Within the Same Category

1B41: Acute rheumatic fever with cardiac involvement

When to use 1B41 vs. 1B40: The code 1B41 should be used whenever there is any evidence of acute rheumatic carditis, while 1B40 is reserved for cases without documented cardiac involvement. This differentiation is critical because the presence of carditis significantly alters prognosis, treatment intensity, and duration of secondary prophylaxis.

Main difference: The fundamental distinction is based on the presence or absence of cardiac manifestations. Code 1B41 applies when there is:

New or altered cardiac murmurs (particularly mitral or aortic regurgitation)
Echocardiographic changes indicative of valvulitis
Pericarditis (clinical or echocardiographic)
Cardiomegaly
Signs of heart failure
Electrocardiographic changes suggestive of myocarditis (beyond simple PR prolongation)

Even subtle echocardiographic findings, if interpreted as acute rheumatic carditis, justify the use of 1B41. Echocardiographic evaluation is fundamental for this differentiation, as it can detect subclinical valvulitis not apparent on clinical examination.

1B42: Rheumatic chorea

When to use 1B42 vs. 1B40: Code 1B42 is specific for cases where Sydenham chorea (minor chorea) is the predominant or isolated manifestation of rheumatic fever. Although chorea may occur concomitantly with other manifestations, when it constitutes the main clinical finding, 1B42 is the most appropriate code.

Main difference: Sydenham chorea is characterized by:

Involuntary, irregular, non-rhythmic and non-repetitive movements
Motor incoordination and muscle weakness
Behavioral changes and emotional lability
Typically later onset than other manifestations (may occur months after streptococcal infection)
May occur in isolation, without other manifestations of rheumatic fever

When a patient presents with arthritis as the predominant manifestation without chorea, code 1B40 is appropriate (if there is no carditis). If chorea is the main manifestation, even without carditis, 1B42 is more specific. In cases with multiple manifestations including chorea, clinical judgment regarding which manifestation is predominant guides coding.

Differential Diagnoses

Post-Infectious Reactive Arthritis: Other infections (gastrointestinal, urogenital) can cause reactive arthritis that mimics rheumatic fever. Differentiation is based on documentation of specific streptococcal infection and fulfillment of Jones criteria. Post-streptococcal reactive arthritis that does not satisfy complete rheumatic fever criteria requires a different code.

Septic Arthritis: Usually monoarticular, with more intense inflammatory signs, high fever, and need for investigation with arthrocentesis. The absence of migratory pattern and presence of severe focal joint involvement help with differentiation.

Juvenile Idiopathic Arthritis: May present with polyarthritis, but generally has no temporal relationship with streptococcal infection, does not satisfy Jones criteria, and has a more chronic course. Markers of streptococcal infection are negative or not significantly elevated.

Systemic Lupus Erythematosus: Can cause arthritis and systemic manifestations, but generally presents with other characteristic findings (specific skin lesions, renal alterations, positive autoantibodies) that allow differentiation.

Lyme Disease: In endemic regions, can cause migratory arthritis, but epidemiologic history, specific serology, and absence of evidence of streptococcal infection allow distinction.

8. Differences with ICD-10

Equivalent ICD-10 Code: In ICD-10, the equivalent code is I00 - Acute rheumatic fever without mention of heart involvement.

Main Changes in ICD-11:

The transition from ICD-10 to ICD-11 brought important modifications in the classification of acute rheumatic fever:

Coding Structure: ICD-11 uses a different alphanumeric system (1B40 vs. I00), reflecting a complete reorganization of the classification structure. The new system allows greater granularity and flexibility for future expansions.

Updated Terminology: ICD-11 uses "without mention of cardiac involvement" instead of "without mention of heart involvement," representing more contemporary and precise terminology.

Clearer Hierarchy: ICD-11 establishes a more explicit hierarchy within acute rheumatic conditions, facilitating navigation and understanding of the relationships between different disease presentations.

Post-coordination Possibility: ICD-11 introduces the concept of post-coordination, allowing additional details to be added to the main code through complementary codes to specify severity, specific manifestations, or other relevant characteristics, although the base code 1B40 remains the primary identifier.

Practical Impact of These Changes:

For healthcare professionals, the most significant change is the need to become familiar with the new alphanumeric coding system. Health information systems needed to be updated to accommodate the new structure. The greater potential specificity of ICD-11 can improve the quality of epidemiological data, but also requires more detailed clinical documentation. The transition may temporarily affect comparisons of historical data, necessitating conversion tables between ICD-10 and ICD-11 for longitudinal analyses. For reimbursement and billing purposes, administrative systems needed to adapt to the new codes, although the essence of the diagnosis remains unchanged.

9. Frequently Asked Questions

1. How is acute rheumatic fever diagnosed without cardiac involvement?

The diagnosis is based on the application of modified Jones criteria, which require evidence of recent streptococcal infection (through culture, rapid antigen test, or elevated anti-streptococcal antibody titers) combined with specific clinical manifestations. It is necessary to identify two major manifestations or one major manifestation with two minor ones. Major manifestations include arthritis, carditis, chorea, erythema marginatum, and subcutaneous nodules. Minor manifestations include fever, arthralgias, elevation of inflammatory markers, and prolongation of the PR interval on electrocardiogram. To confirm the absence of cardiac involvement, it is essential to perform complete cardiovascular evaluation, including detailed physical examination, electrocardiogram, and ideally, echocardiogram. The absence of new cardiac murmurs, echocardiographic valvular alterations, cardiomegaly, or signs of pericarditis confirms that there is no carditis, justifying the use of code 1B40.

2. Is treatment available in public health systems?

Yes, treatment for acute rheumatic fever is generally available in public health systems in most countries. Essential medications include antibiotics (benzathine penicillin for streptococcal eradication and secondary prophylaxis) and anti-inflammatory agents (aspirin or other nonsteroidal anti-inflammatory drugs for control of articular symptoms). These are relatively accessible medications and widely available. Benzathine penicillin, in particular, is included in the essential medicines list of international health organizations. The greater challenge often lies not in medication availability, but in the capacity to perform adequate diagnosis (including echocardiography) and maintain long-term follow-up with regular secondary prophylaxis. Rheumatic fever control programs in various countries have demonstrated that organized strategies for primary and secondary prevention are viable and effective even in resource-limited settings.

3. How long does treatment last?

Treatment of acute rheumatic fever without cardiac involvement has two distinct phases. The acute phase involves treatment with antibiotics (benzathine penicillin in a single dose to eradicate streptococci) and anti-inflammatory agents for a period that typically varies from 2 to 4 weeks, depending on clinical response and resolution of articular symptoms. More important is the secondary prophylaxis phase, which aims to prevent recurrences through regular administration of benzathine penicillin (generally every 21-28 days). The duration of secondary prophylaxis in patients without carditis is generally at least 5 years after the last episode or until age 21, whichever is longer. This duration may be adjusted based on individual risk factors, exposure to high-risk environments for streptococcal infection, and local epidemiological characteristics. Clinical follow-up should be maintained throughout this period, with periodic reevaluations including cardiovascular assessment.

4. Can this code be used in medical certificates?

Yes, code 1B40 can and should be used in medical certificates when appropriate, as it represents a legitimate and specific medical diagnosis. However, it is important to consider the context and purpose of the certificate. For certificates of absence from work or school during the acute phase, the code adequately documents the condition that justifies temporary absence. For documentation of long-term follow-up or justification of the need for continuous secondary prophylaxis, the code is also appropriate. It is recommended that certificates include not only the ICD code, but also a clear description of the condition in understandable language. For purposes of prolonged medical leave or health-related benefits, additional documentation may be necessary detailing severity, treatment, and prognosis. It is worth noting that, although code 1B40 indicates absence of cardiac involvement in the acute episode, the condition still requires careful follow-up and long-term prophylaxis, which should be communicated appropriately.

5. What is the difference between rheumatic fever with and without cardiac involvement in terms of prognosis?

The prognosis of acute rheumatic fever is significantly better when there is no cardiac involvement. Patients with code 1B40 (without carditis) generally present complete recovery of articular manifestations and other acute symptoms without permanent sequelae. The risk of developing chronic rheumatic heart disease is substantially lower compared to patients who present with carditis in the acute episode. However, it is important to emphasize that even patients without initial carditis remain at risk for recurrences of rheumatic fever if they do not maintain adequate secondary prophylaxis, and recurrent episodes may eventually cause cardiac damage. Therefore, secondary prophylaxis is essential even in cases without initial cardiac involvement. Additionally, some studies suggest that a small proportion of patients may develop subclinical valvulopathy detectable only with follow-up echocardiography, reinforcing the importance of periodic cardiovascular monitoring even in cases initially classified as 1B40.

6. Is it possible to have rheumatic fever more than once?

Yes, recurrences of rheumatic fever are possible and represent a significant concern in the management of this condition. Patients who have had an episode of rheumatic fever have increased risk of new episodes if they are reinfected with group A streptococci. This risk is particularly high in the first years after the initial episode and in individuals who do not maintain adequate secondary prophylaxis. Each recurrence increases the risk of development or worsening of rheumatic heart disease, even if the initial episode did not involve the heart. For this reason, secondary prophylaxis with regular benzathine penicillin is fundamental to prevent recurrences. A patient who had rheumatic fever coded as 1B40 (without carditis) in one episode may develop carditis in a recurrent episode, then requiring coding as 1B41. Prevention of recurrences through adequate prophylaxis is one of the pillars of rheumatic fever management and has direct impact on prevention of chronic rheumatic heart disease.

7. Are children and adults affected in the same way?

Acute rheumatic fever predominantly affects children and adolescents between 5 and 15 years of age, being relatively rare in adults and children under 3 years of age. When it occurs in adults, it generally represents recurrence in individuals with previous history of the disease, although cases of first episode in adults may occasionally occur. Clinical manifestations are generally similar across different age groups, although some differences may be observed: Sydenham's chorea is more common in younger children and in girls; adults may present with more prolonged articular manifestations. Diagnosis in adults may be more challenging due to the higher prevalence of other articular conditions and the possible absence of clear history of streptococcal pharyngitis. Regardless of age, diagnostic criteria and coding follow the same principles, and code 1B40 is applicable when there is acute rheumatic fever without cardiac involvement, regardless of the patient's age group.

8. What are the risks of not treating this condition adequately?

Failure to treat or inadequate treatment of acute rheumatic fever, even without initial cardiac involvement, carries significant risks. The most important risk is that of recurrences, which are more likely in the absence of adequate secondary prophylaxis. Each recurrent episode substantially increases the risk of development of carditis and, consequently, of chronic rheumatic heart disease with permanent valvulopathies. Even if the initial episode is coded as 1B40 (without carditis), recurrences may involve the heart, resulting in progressive valvular damage. Additionally, there is evidence that some patients may develop subclinical valvulopathy even after a single episode apparently without carditis, particularly if not treated adequately. Acute articular symptoms, although generally self-limited, may cause significant morbidity and temporary disability if untreated. In the long term, the absence of secondary prophylaxis exposes the patient to continuous risk of streptococcal reinfection and new episodes of rheumatic fever, with potential for serious cardiac complications, including heart failure, need for valve surgery, and premature mortality. Therefore, even in cases without initial cardiac involvement, adequate treatment and secondary prophylaxis are essential to prevent long-term complications.

Conclusion:

The ICD-11 code 1B40 - Acute rheumatic fever without mention of cardiac involvement - represents a specific and clinically relevant classification within the spectrum of acute rheumatic fever. The correct application of this code requires clear understanding of diagnostic criteria, adequate cardiovascular evaluation to confirm absence of carditis, and careful differentiation from other presentations of rheumatic fever and similar conditions. Although these patients present more favorable prognosis than those with cardiac involvement, they still require appropriate treatment, prolonged secondary prophylaxis, and regular clinical follow-up. Precise coding not only facilitates clinical and administrative documentation, but also contributes to epidemiological surveillance, planning of public health programs, and adequate allocation of resources for control of this condition which, although preventable, continues to represent an important health problem in various regions of the world.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Acute Rheumatic Fever without mention of cardiac involvement

Share